NCT05405075 · RECRUITING

Arizona Alzheimer's Disease Research Center (ADRC)

The Arizona ADRC is a research registry and data-collection program, not a drug or treatment trial. Participants — ranging from cognitively normal adults to those with MCI or dementia — undergo cognitive testing, brain imaging, and blood draws for genetic and biomarker research. There is no experimental intervention. This is ongoing observational science aimed at better understanding how Alzheimer's develops over time. No phase designation applies because nothing is being tested for efficacy.

You may qualify if

  • Cognitively normal persons, individuals with mild cognitive impairment or dementia who are at least 40 years of age.
  • Willing to undergo health and cognitive assessments, and collection and banking of blood with venipuncture for genetic research, biomarker research, and DNA banking.

You're excluded if

  • 1. Participants whose diagnosis is unclear and confounded by multiple possible factors are excluded. Participants with diagnoses of non-AD dementias are not excluded. 2. Participants whose primary diagnosis is cognitive impairment due to a penetrating or single severe closed head injury, multiple sclerosis, brain tumor, metabolic or toxic encephalopathy, post-infectious (e.g., viral encephalitis, bacterial meningitis), paraneoplastic, primary psychiatric illness, or otherwise not deemed relevant to the intent of the Alzheimer Disease Center program are excluded. 3. Procedure specific exclusion criteria also apply but this does not impact the participants ability to be included in the study.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-08-19

View full record on ClinicalTrials.gov

All APOE4 clinical trials